Medimmune

Advanced BioScience Laboratories began as Bionetics Research Laboratories, which was established in 1961 to conduct biomedical contract research. In 1968, Bionetics was acquired by Litton Industries and became Litton Bionetics. The company was awarded the initial National Cancer Institute (NCI) contract in 1972 to convert what was then the Fort Detrick Biological Warfare Facilities into what became the NCI-Frederick Cancer Research and Development Center, and to establish the technical and scientific programs at the site. Advanced BioScience Laboratories is a wholly owned subsidiary of bioM rieux.

Curesearch is a nonprofit organization based in Bethesda, MD, dedicated to funding research to find cures for children's cancer. They work with leading researchers and institutions to support innovative studies and clinical trials aimed at improving treatment outcomes. Through collaboration and advocacy, Curesearch strives to accelerate the discovery of new therapies and ultimately improve the quality of life for children battling cancer. Their mission is to make a meaningful impact in the fight against pediatric cancer through research and education initiatives. Generated from their business information

The National Pharmaceutical Council (NPC) is dedicated to advancing patient access to innovative medicines through policy-relevant research that emphasizes the value of scientific advancement. With a vision of a healthcare landscape where medical innovations are accessible and sustainably reimbursed, NPC engages in shaping policy discussions and providing evidence to support the importance of innovation in medicine. As a Certified Great Place To Work, NPC fosters a collaborative environment where research informs media narratives, Congressional testimony, and public understanding of the future of patient access. Their commitment to transparency and evidence-based policy ensures that the significance of innovative therapies is recognized and valued by society. Generated from the website